Sale!

ADA2 Gene Polyarteritis Nodosa Childhood-Onset NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The ADA2 Gene Polyarteritis Nodosa Childhood-Onset NGS Genetic DNA Test is a comprehensive genetic analysis that identifies mutations in the ADA2 gene responsible for causing childhood-onset polyarteritis nodosa. This specialized test utilizes next-generation sequencing technology to detect specific genetic variations that lead to severe vascular inflammation and systemic complications in children. Early detection through this $500 USD test enables timely intervention and personalized treatment strategies. The test is particularly crucial for children presenting with unexplained fevers, skin lesions, neurological symptoms, or systemic inflammation. Results provide valuable information for family planning and genetic counseling. Our advanced NGS methodology ensures high accuracy and comprehensive coverage of the ADA2 gene. Testing is available at our nationwide network of diagnostic centers across the United States.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

ADA2 Gene Polyarteritis Nodosa Childhood-Onset NGS Genetic DNA Test

Comprehensive Genetic Analysis for Childhood Vascular Disorders

The ADA2 Gene Polyarteritis Nodosa Childhood-Onset NGS Genetic DNA Test represents a breakthrough in pediatric genetic diagnostics, specifically designed to identify mutations in the ADA2 gene that cause severe inflammatory vascular conditions in children. This advanced genetic screening utilizes cutting-edge next-generation sequencing technology to provide accurate and comprehensive analysis of the ADA2 gene, enabling early diagnosis and targeted treatment strategies for affected children.

What This Test Measures and Detects

This specialized genetic test focuses on identifying pathogenic variants in the ADA2 (adenosine deaminase 2) gene, which plays a critical role in maintaining vascular integrity and immune system regulation. The test specifically detects:

  • Point mutations and small insertions/deletions in the ADA2 gene
  • Missense, nonsense, and frameshift mutations affecting protein function
  • Genetic variants associated with impaired adenosine deaminase 2 enzyme activity
  • Hereditary patterns of ADA2 deficiency that cause childhood-onset polyarteritis nodosa

Who Should Consider This Test

This genetic test is particularly recommended for children and adolescents presenting with the following symptoms or clinical features:

  • Unexplained recurrent fevers lasting more than two weeks
  • Characteristic skin lesions including livedo reticularis or nodular eruptions
  • Neurological symptoms such as strokes, seizures, or developmental regression
  • Systemic inflammation with elevated inflammatory markers
  • Family history of similar vascular or autoimmune conditions
  • Early-onset hypertension or renal involvement
  • Gastrointestinal symptoms including abdominal pain and bleeding

Key Benefits of Genetic Testing

Undergoing the ADA2 Gene Polyarteritis Nodosa Childhood-Onset NGS Genetic DNA Test provides numerous critical advantages:

  • Early and Accurate Diagnosis: Enables precise identification of the underlying genetic cause of symptoms
  • Personalized Treatment Planning: Guides targeted therapeutic interventions based on genetic findings
  • Family Planning Guidance: Provides essential information for genetic counseling and family planning decisions
  • Prevention of Complications: Early detection helps prevent serious vascular and neurological complications
  • Comprehensive Genetic Analysis: NGS technology ensures thorough examination of the entire ADA2 gene

Understanding Your Test Results

Your genetic test results will be carefully interpreted by our team of certified genetic counselors and medical geneticists. Results typically fall into one of these categories:

  • Positive Result: Identification of pathogenic ADA2 gene mutations confirms the diagnosis of ADA2 deficiency and guides specific treatment approaches
  • Negative Result: No disease-causing mutations detected, suggesting alternative diagnoses should be considered
  • Variant of Uncertain Significance: Genetic changes identified require further clinical correlation and family studies
  • Carrier Status: Identification of individuals who carry one copy of the mutated gene but may not show symptoms

Test Pricing and Availability

Price Type Amount (USD)
Discount Price $500
Regular Price $700

Nationwide Testing Availability

We have diagnostic centers conveniently located across the United States, including major metropolitan areas such as New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our comprehensive network ensures accessible genetic testing services for families throughout the country.

Take Action for Your Child’s Health

Early genetic testing can make a significant difference in managing childhood-onset polyarteritis nodosa. Our experienced genetic counselors and medical specialists are available to discuss your child’s symptoms and determine if this test is appropriate. Contact us today to schedule your consultation and genetic testing appointment.

Call or WhatsApp us at +1(267) 388-9828 to book your ADA2 Gene Polyarteritis Nodosa Childhood-Onset NGS Genetic DNA Test today and take the first step toward accurate diagnosis and targeted treatment.